Dermatology Times

MARCH 4, 2024

Raj Chovatiya, MD, PhD, gives a sneak peek of what to expect in atopic dermatitis education at the 2024 American Academy of Dermatology (AAD) Meeting in San Diego, California March 8-12. Since the last meeting, the AAD has released new guidelines to treat the condition.

Dermatitis 74

Dermatitis Education Dermatology 74

The Dermatology Digest

MARCH 7, 2024

Elizabeth (Lisa) Swanson, MD, a pediatric dermatologist in Boise, ID, discusses advances in treating kids with atopic dermatitis, psoriasis, vitiligo, alopecia areata, and hemangiomas. Watch Now [the_ad id="7336"] [the_ad id="8980"] The post Welcome to the Golden Age of Pediatric Dermatology appeared first on The Dermatology Digest.

Dermatology 68

Dermatology Dermatitis Therapy 68

Dermatology Times

MAY 15, 2024

In this month’s Cosmetic Conundrums column, explore what dermatology clinicians need to know about false eyelashes to help prevent infections or contact dermatitis.

Dermatology 74

Dermatology Dermatitis 74

Dermatology Times

OCTOBER 31, 2024

Egeberg discusses promising new treatments and insights from recent clinical trials, highlighting significant advancements in chronic hand eczema and atopic dermatitis care presented at the EADV 2024.

Eczema 74

Eczema Dermatitis Clinic Treatments 74

Dermatology Times

DECEMBER 18, 2023

Raj Chovatiya, MD, PhD introduces a video series program exploring cutting-edge treatments at the forefront of atopic dermatitis management, exploring innovative insights and research that will redefine dermatological care.

Dermatitis 36

Dermatitis Dermatology Innovations Management 36

Dermatology Times

OCTOBER 1, 2023

October is Eczema Awareness Month and Dermatology Times is recognizing research to best serve patients with the most common type of eczema, atopic dermatitis.

Dermatitis 74

Dermatitis Eczema Dermatology 74

Dermatology Times

MAY 29, 2024

Learn more about the in-depth topics covered in the March 2024 supplement of Dermatology Times.

Dermatology 74

Dermatology Dermatitis 74

Dermatology Times

APRIL 5, 2024

Mark Lebwohl, MD, emphasizes the importance of considering various factors, including severity of itch and interference with sleep, when determining treatments for patients with atopic dermatitis, even with presentation may not include typical symptoms.

Dermatitis 87

Dermatitis Treatments 87

Dermatology Times

OCTOBER 3, 2024

Jason Hawkes, MD, MS, emphasized the importance of biologic treatments transforming the management of both prurigo nodularis and atopic dermatitis.

Dermatitis 74

Dermatitis Clinic Management Treatments 74

Dermatology Times

DECEMBER 5, 2023

Zakiya Pressley Rice, MD, took a deep dive into how atopic dermatitis severity and increased rates of grade school absenteeism affect patients with skin of color during a recent Masterclasses in Dermatology meeting.

Dermatitis 78

Dermatitis Dermatology 78

Dermatology Times

JUNE 9, 2024

Jonathan Silverberg, MD, PhD, MPH, presented his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities.

Dermatitis 92

Dermatitis 92

Dermatology Times

JUNE 10, 2024

David Rosmarin, MD, shares key points from phase 3 data of ruxolitinib for vitiligo, as well as highlights the potential for targeting the STAT pathway in upcoming atopic dermatitis therapeutics.

Dermatitis 85

Dermatitis 85

The Dermatology Digest

FEBRUARY 8, 2024

The Dermatology Digest asked key thought leaders and editorial advisory board members to take out their crystal balls and weigh in on what’s to come in 2024 and beyond. Inside the Burgeoning AD Pipeline AD is another dermatologic condition that is undergoing a transformation in terms of treatment options and paradigms.

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

First Derm

FEBRUARY 21, 2024

Eczema (Atopic Dermatitis) Eczema, also known as atopic dermatitis, is a common skin condition characterized by characterized by impaired skin barrier function, intense itching, recurrent eczematous lesions, and is often associated with other allergic conditions. [1] Contact dermatitis from metals, latex, chemicals.

Eczema 59

Eczema Dermatitis Management Medical 59

Dermatology Times

JUNE 10, 2024

Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more.

Dermatitis 74

Dermatitis 74

Dermatology Times

JUNE 1, 2024

Raj Chovatiya, MD, PhD, takes a deep dive in the challenges, solutions, and further research needed to treat seborrheic dermatitis.

Dermatitis 80

Dermatitis Treatments 80

Dermatology Times

APRIL 19, 2024

Michael Cameron, MD, identifies the most important pearls from the latest atopic dermatitis treatment guidelines set forth by the American Academy of Dermatology.

Dermatitis 36

Dermatitis Dermatology Treatments 36

Dermatology Times

MAY 30, 2024

Raj Chovatiya, MD, PhD, reviews the varying degrees of influence of skin barrier disruption, immune dysregulation, and Malassezia yeast in seborrheic dermatitis.

Dermatitis 74

Dermatitis 74

Dermatology Times

OCTOBER 27, 2024

At Fall Clinical 2024, Christopher Bunick, MD, PhD, discussed systemic therapy options and the importance of comprehensive treatment targets in managing atopic dermatitis, emphasizing AHEAD recommendations and LEVEL UP data.

Dermatitis 53

Dermatitis Treatments Therapy Management 53

MedEsthetics

AUGUST 11, 2023

atopic dermatitis, acne, inflammatory conditions, skincare, acne treatment, peptide, medical aesthetics, clinical trials, phase 1 study, British journal of dermatology

Dermatitis 60

Dermatitis Skincare Clinic Medical 60

Dermatology Times

JUNE 11, 2024

Gil Yosipovitch, MD, addresses the severity of chronic itch and sleep disturbances in patients with atopic dermatitis.

Dermatitis 77

Dermatitis 77

Dermatology Times

AUGUST 27, 2024

The AHEAD recommendations focus on achieving disease control in atopic dermatitis by allowing patients to identify key symptoms and clinicians to select matching outcomes to guide therapy, aiming for a higher standard of care.

Dermatitis 45

Dermatitis Treatments Therapy 45

Dermatology Times

APRIL 12, 2024

Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and oral contraceptives. She also addresses potential drug interactions, focusing on the safety of dupilumab in systemic treatment.

Dermatitis 85

Dermatitis Treatments Safety Management 85

West Lake Dermatology

MARCH 25, 2024

Seborrheic Dermatitis (SD) is common skin condition known for its chronic and recurrent nature. Understanding seborrheic dermatitis is the first step towards managing it effectively. What Is Seborrheic Dermatitis? Who’s At Risk For Developing Seborrheic Dermatitis? SD can affect individuals of all ages and races.

Dermatitis 36

Dermatitis Treatments Eczema Management 36

Dermatology Times

JANUARY 11, 2024

Innovative practice pearls for both vitiligo and atopic dermatitis treatment were shared with nearly 200 clinicians to put into practice at the virtual Revolutionizing Vitiligo and Revolutionizing Atopic Dermatitis Conferences.

Dermatitis 74

Dermatitis Innovations Treatments 74

Dermatology Times

NOVEMBER 4, 2023

Test your knowledge on approved biologics in the management of moderate to severe atopic dermatitis and considerations for an 18-year-old man's case.

Dermatitis 78

Dermatitis Management 78

Dermatology Times

JUNE 27, 2024

A dermatology expert reviews findings from a recently presented study on using other atopic dermatitis (AD) treatments within six months of initiating ruxolitinib cream.

Dermatitis 36

Dermatitis Management Treatments Dermatology 36

Dermatology Times

JUNE 11, 2024

Kristine Kucera, PA-C, MPAS, DHS, discusses the atopic dermatitis patient experience alongside one of her patients, Mickey Bryson.

Dermatitis 74

Dermatitis 74

Dermatology Times

JULY 13, 2024

Lio discusses his SPD 2024 non-CME talk, new and exciting innovations in pediatric atopic dermatitis, and more.

Dermatitis 78

Dermatitis Innovations 78

The Dermatology Digest

OCTOBER 29, 2024

Linda Stein Gold, MD, Director of Dermatology Clinical Research at Henry Ford Health System in Detroit, MI, reviews new data on atopic dermatitis (AD) patients who switched to lebrikizumab (Ebyglyss, Lilly) from dupilumab (Dupixent, Sanofi and Regeneron) that was presented at the 2024 Fall Clinical Dermatology Conference in Las Vegas, NV. “If

Dermatitis 74

Dermatitis Dermatology Clinic Treatments 74

Dermatology Times

NOVEMBER 14, 2024

Poster compared quality of life improvement for dupilumab vs lebrikizumab in atopic dermatitis.

Dermatitis 48

Dermatitis 48

The Dermatology Digest

OCTOBER 8, 2024

April Armstrong, MD, Professor and Chief of Dermatology at University of California-Los Angeles (UCLA), shares interim results from the TRACE study. The post Real-world Data: Tralokinumab Improves Head and Neck AD appeared first on The Dermatology Digest. at baseline to 33.6% at three months, 48.4% at six months, and 57.4%

Dermatitis 74

Dermatitis Dermatology Treatments 74

Dermatology Times

JULY 30, 2024

Learn more about the in-depth topics covered in the July 2024 supplement of Dermatology Times.

Dermatology 41

Dermatology Dermatitis 41

The Dermatology Digest

SEPTEMBER 17, 2024

Alexis, MD, MPH, Professor of Clinical Dermatology at Weill Cornell Medicine in New York, NY, discusses preliminary study results showing that the newly U.S. The post Newly Approved Lebrikizumab Shows Promise in Patients With Darker Skin and AD appeared first on The Dermatology Digest.

Hyperpigmentation 74

Hyperpigmentation Dermatitis Dermatology Clinic 74

Dermatology Times

JANUARY 9, 2024

Test your knowledge and explore a recent study on the relationship between alcohol consumption and skin diseases, including atopic dermatitis.

Dermatitis 74

Dermatitis 74

Dermatology Times

NOVEMBER 10, 2023

A new study presented at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting highlights the need for mental health support in patients with atopic dermatitis.

Dermatitis 78

Dermatitis 78

Dermatology Times

APRIL 18, 2024

Researchers noted that further examination and monitoring for headache disorders in patients with atopic dermatitis may be warranted.

Dermatitis 78

Dermatitis 78